Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy

Recruiting now · Not applicable

Conditions studied: Esophageal Squamous Cell Carcinoma

In brief

The goal of this study was to explore the efficacy and safety of neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy in patients with locally advanced esophageal squamous cell carcinoma

Key facts

Study ID
NCT06602843
Run by
Anhui Provincial Hospital
People needed
70
Starts
2024-01-01
Expected to finish
2026-12-31
Last updated by the study team
2024-09-19

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.